236 related articles for article (PubMed ID: 32304700)
1. A TfR-Binding Cystine-Dense Peptide Promotes Blood-Brain Barrier Penetration of Bioactive Molecules.
Crook ZR; Girard E; Sevilla GP; Merrill M; Friend D; Rupert PB; Pakiam F; Nguyen E; Yin C; Ruff RO; Hopping G; Strand AD; Finton KAK; Coxon M; Mhyre AJ; Strong RK; Olson JM
J Mol Biol; 2020 Jun; 432(14):3989-4009. PubMed ID: 32304700
[TBL] [Abstract][Full Text] [Related]
2. VHHs as tools for therapeutic protein delivery to the central nervous system.
Wouters Y; Jaspers T; Rué L; Serneels L; De Strooper B; Dewilde M
Fluids Barriers CNS; 2022 Oct; 19(1):79. PubMed ID: 36192747
[TBL] [Abstract][Full Text] [Related]
3. Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier.
Stanimirovic DB; Sandhu JK; Costain WJ
BioDrugs; 2018 Dec; 32(6):547-559. PubMed ID: 30306341
[TBL] [Abstract][Full Text] [Related]
4. Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases.
Zhou X; Smith QR; Liu X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1695. PubMed ID: 33470550
[TBL] [Abstract][Full Text] [Related]
5. Blood-brain barrier drug delivery of IgG fusion proteins with a transferrin receptor monoclonal antibody.
Pardridge WM
Expert Opin Drug Deliv; 2015 Feb; 12(2):207-22. PubMed ID: 25138991
[TBL] [Abstract][Full Text] [Related]
6. Peptide therapeutics for CNS indications.
McGonigle P
Biochem Pharmacol; 2012 Mar; 83(5):559-66. PubMed ID: 22051078
[TBL] [Abstract][Full Text] [Related]
7. Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair.
Sharma A; Menon P; Muresanu DF; Ozkizilcik A; Tian ZR; Lafuente JV; Sharma HS
CNS Neurol Disord Drug Targets; 2016; 15(9):1092-1117. PubMed ID: 27538949
[TBL] [Abstract][Full Text] [Related]
8. Targeting the transferrin receptor for brain drug delivery.
Johnsen KB; Burkhart A; Thomsen LB; Andresen TL; Moos T
Prog Neurobiol; 2019 Oct; 181():101665. PubMed ID: 31376426
[TBL] [Abstract][Full Text] [Related]
9. Targeting Ligands Deliver Model Drug Cargo into the Central Nervous System along Autonomic Neurons.
Sellers DL; Tan JY; Pineda JMB; Peeler DJ; Porubsky VL; Olden BR; Salipante SJ; Pun SH
ACS Nano; 2019 Oct; 13(10):10961-10971. PubMed ID: 31589023
[TBL] [Abstract][Full Text] [Related]
10. Muscone/RI7217 co-modified upward messenger DTX liposomes enhanced permeability of blood-brain barrier and targeting glioma.
Kang S; Duan W; Zhang S; Chen D; Feng J; Qi N
Theranostics; 2020; 10(10):4308-4322. PubMed ID: 32292496
[No Abstract] [Full Text] [Related]
11. Applications of nanotechnology in drug delivery to the central nervous system.
Saeedi M; Eslamifar M; Khezri K; Dizaj SM
Biomed Pharmacother; 2019 Mar; 111():666-675. PubMed ID: 30611991
[TBL] [Abstract][Full Text] [Related]
12. Advanced translational PBPK model for transferrin receptor-mediated drug delivery to the brain.
Sato S; Liu S; Goto A; Yoneyama T; Okita K; Yamamoto S; Hirabayashi H; Iwasaki S; Kusuhara H
J Control Release; 2023 May; 357():379-393. PubMed ID: 37031741
[TBL] [Abstract][Full Text] [Related]
13. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
Begley DJ
Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
[TBL] [Abstract][Full Text] [Related]
14. A New Noncanonical Anionic Peptide That Translocates a Cellular Blood-Brain Barrier Model.
Neves-Coelho S; Eleutério RP; Enguita FJ; Neves V; Castanho MARB
Molecules; 2017 Oct; 22(10):. PubMed ID: 29057814
[TBL] [Abstract][Full Text] [Related]
15. Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies.
Smith MW; Gumbleton M
J Drug Target; 2006 May; 14(4):191-214. PubMed ID: 16777679
[TBL] [Abstract][Full Text] [Related]
16. From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery.
Banks WA
Nat Rev Drug Discov; 2016 Apr; 15(4):275-92. PubMed ID: 26794270
[TBL] [Abstract][Full Text] [Related]
17. Drug delivery systems, CNS protection, and the blood brain barrier.
Upadhyay RK
Biomed Res Int; 2014; 2014():869269. PubMed ID: 25136634
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system delivery of molecules across the blood-brain barrier.
Gosselet F; Loiola RA; Roig A; Rosell A; Culot M
Neurochem Int; 2021 Mar; 144():104952. PubMed ID: 33400964
[TBL] [Abstract][Full Text] [Related]
19. Strategies for transporting nanoparticles across the blood-brain barrier.
Zhang TT; Li W; Meng G; Wang P; Liao W
Biomater Sci; 2016 Feb; 4(2):219-29. PubMed ID: 26646694
[TBL] [Abstract][Full Text] [Related]
20. Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: trends and advances.
Goyal K; Koul V; Singh Y; Anand A
Cent Nerv Syst Agents Med Chem; 2014; 14(1):43-59. PubMed ID: 25360772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
